# Evaluation of the Antihypertensive Effect of Hyzaar(R) and Cognitive Function of Hypertensive Patients (0954A-322)

> **NCT00398541** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 41 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** losartan potassium (+) hydrochlorothiazide

## Key facts

- **NCT ID:** NCT00398541
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03-01
- **Primary completion:** 2007-04-10
- **Final completion:** 2007-06-01
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00398541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00398541, "Evaluation of the Antihypertensive Effect of Hyzaar(R) and Cognitive Function of Hypertensive Patients (0954A-322)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00398541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*